Abstract
Background:
A specific ‘adipose tissue’ microbiota has been recently identified in mice and hypothesized in humans. The purpose of this study was to verify the presence of microbiota of human whole adipose tissue and isolated adipocytes by combining culture-dependent and independent methods.
Methods:
Standard microbiological cultural techniques and 16S ribosomal RNA (16S rRNA) gene sequencing (Illumina technology) on DNA and RNA were employed to study (a) whole abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) from 14 obese and five normal-weight subjects and (b) mature adipocytes isolated from SAT and VAT after collagenase digestion or mechanical separation. To optimize the 16S rRNA gene detection, we used different DNA extraction methods (lysis with proteinase K, proteinase K+lysozyme and microbeads) and amplification procedures (semi-quantitative standard PCR and real-time quantitative PCR).
Results:
Microbiological cultures were negative in all analyzed samples. In enzymatically isolated adipocytes, 90% of the sequenced bacterial DNA belonged to Clostridium histolyticum, the bacterium from which the collagenase enzyme was isolated. Bacterial 16S rRNA gene was not detected from DNA and RNA of whole SAT and VAT, as well as of mechanically isolated mature adipocytes, even after blocking with a specific primer the nonspecific amplification of human mitochondrial 12S rRNA.
Conclusions:
Our results do not support the presence of a human adipose tissue microbiota. In addition, they emphasized the technical problems encountered when applying metagenomic studies to human tissues with very low or absent bacterial load.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R . Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694–1697.
Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ . Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 2015; 26: 26191.
Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS . Application of metagenomics in the human gut microbiome. World J Gastroenterol 2015; 21: 803–814.
Amar J, Lange C, Payros G, Garret C, Chabo C, Lantieri O et al. Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One 2013; 8: e54461.
Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL . The microbiome extends to subepidermal compartments of normal skin. Nat Commun 2013; 4: 1431.
Francavilla R, Ercolini D, Piccolo M, Vannini L, Siragusa S, De Filippis F et al. Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol 2014; 80: 3416–3425.
Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2011; 108: 4592–4598.
Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470–1481.
Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012; 61: 543–553.
Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD . Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 2014; 5: 3–17.
Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermúdez-Humarán LG et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559–572.
Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012; 61: 78–85.
Zulian A, Cancello R, Ruocco C, Gentilini D, Di Blasio AM, Danelli P et al. Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study. PLoS One 2013; 24: 8.
Lluch J, Servant F, Païssé S, Valle C, Valière S, Kuchly C et al. The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS One 2015; 10: e0142334.
Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C . Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012; 32: 637–647.
Zulian A, Cancello R, Micheletto G, Gentilini D, Gilardini L, Danelli P et al. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? Gut 2012; 61: 86–94.
Claesson MJ, Wang Q, O'Sullivan O, Greene-Diniz R, Cole JR, Ross RP et al. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res 2010; 38: e200.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ . Basic local alignment search tool. J Mol Biol 1990; 215: 403–410.
Burcelin R, Serino M, Chabo C, Garidou L, Pomié C, Courtney M et al. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab 2013; 15: 61–70.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Zulian, A., Cancello, R., Cesana, E. et al. Adipose tissue microbiota in humans: an open issue. Int J Obes 40, 1643–1648 (2016). https://doi.org/10.1038/ijo.2016.111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2016.111
This article is cited by
-
Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved
Internal and Emergency Medicine (2023)
-
Microbiota in mesenteric adipose tissue from Crohn’s disease promote colitis in mice
Microbiome (2021)
-
Erhöhte Darmpermeabilität: Pathomechanismus für metabolische Erkrankungen?
Der Diabetologe (2021)